206 related articles for article (PubMed ID: 16956689)
1. In addition to obesity and insulin resistance, microalbuminuria and diminished insulin secretion are linked with the metabolic syndrome in community-dwelling nondiabetic Taiwanese subjects.
Yang YC; Wu JS; Lu FH; Chang WC; Wu CH; Chang CJ
Diabetes Res Clin Pract; 2007 Apr; 76(1):102-10. PubMed ID: 16956689
[TBL] [Abstract][Full Text] [Related]
2. Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.
Fiorentino TV; Hribal ML; Andreozzi F; Perticone M; Sciacqua A; Perticone F; Sesti G
Nutr Metab Cardiovasc Dis; 2015 May; 25(5):510-7. PubMed ID: 25813686
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of microalbuminuria in obese children and its relation to metabolic syndrome.
Sanad M; Gharib A
Pediatr Nephrol; 2011 Dec; 26(12):2193-9. PubMed ID: 21638155
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.
Gupta A; Gupta R; Sarna M; Rastogi S; Gupta VP; Kothari K
Diabetes Res Clin Pract; 2003 Jul; 61(1):69-76. PubMed ID: 12849925
[TBL] [Abstract][Full Text] [Related]
5. Clustering of cardiovascular risk factors associated with the insulin resistance syndrome: assessment by principal component analysis in young hyperandrogenic women.
Zanolin ME; Tosi F; Zoppini G; Castello R; Spiazzi G; Dorizzi R; Muggeo M; Moghetti P
Diabetes Care; 2006 Feb; 29(2):372-8. PubMed ID: 16443890
[TBL] [Abstract][Full Text] [Related]
6. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women?
Halimi JM; Forhan A; Balkau B; Novak M; Wilpart E; Tichet J; Marre M;
J Cardiovasc Risk; 2001 Jun; 8(3):139-46. PubMed ID: 11455845
[TBL] [Abstract][Full Text] [Related]
7. Relationship between neck circumference, insulin resistance and arterial stiffness in overweight and obese subjects.
Fantin F; Comellato G; Rossi AP; Grison E; Zoico E; Mazzali G; Zamboni M
Eur J Prev Cardiol; 2017 Sep; 24(14):1532-1540. PubMed ID: 28728486
[TBL] [Abstract][Full Text] [Related]
8. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
Meigs JB; D'Agostino RB; Wilson PW; Cupples LA; Nathan DM; Singer DE
Diabetes; 1997 Oct; 46(10):1594-600. PubMed ID: 9313755
[TBL] [Abstract][Full Text] [Related]
9. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature.
Maison P; Byrne CD; Hales CN; Day NE; Wareham NJ
Diabetes Care; 2001 Oct; 24(10):1758-63. PubMed ID: 11574438
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and factor analysis of metabolic syndrome in an urban Korean population.
Oh JY; Hong YS; Sung YA; Barrett-Connor E
Diabetes Care; 2004 Aug; 27(8):2027-32. PubMed ID: 15277435
[TBL] [Abstract][Full Text] [Related]
11. Leptin and other components of the Metabolic Syndrome in Mauritius--a factor analysis.
Hodge AM; Boyko EJ; de Courten M; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
Int J Obes Relat Metab Disord; 2001 Jan; 25(1):126-31. PubMed ID: 11244468
[TBL] [Abstract][Full Text] [Related]
12. Factor analysis of metabolic syndrome components in obese women.
Lafortuna CL; Adorni F; Agosti F; Sartorio A
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai].
Li Q; Jia WP; Lu JQ; Chen L; Wu YM; Jiang SY; Xiang KS
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jan; 25(1):65-8. PubMed ID: 15061951
[TBL] [Abstract][Full Text] [Related]
14. Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects.
Woo J; Cockram CS; Swaminathan R; Lau E; Chan A; Cheung R
Int J Cardiol; 1992 Dec; 37(3):345-50. PubMed ID: 1468818
[TBL] [Abstract][Full Text] [Related]
15. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
[TBL] [Abstract][Full Text] [Related]
16. [Leptin and clustering of the components of risk factors for metabolic syndrome].
Li M; Wu CY; Zhan ZW; Li XG; Zhang K; Xiang HD
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jul; 38(4):226-30. PubMed ID: 15312578
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria, a parameter independent of metabolic influences in hypertensive men.
Pedrinelli R; Dell'Omo G; Penno G; Di Bello V; Giorgi D; Pellegrini G; Del Prato S; Mariani M
J Hypertens; 2003 Jun; 21(6):1163-9. PubMed ID: 12777954
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose.
Wang JJ; Qiao Q; Miettinen ME; Lappalainen J; Hu G; Tuomilehto J
Diabetes Care; 2004 Oct; 27(10):2429-37. PubMed ID: 15451912
[TBL] [Abstract][Full Text] [Related]
19. Leptin and metabolic syndrome in obese and non-obese children.
Moreno LA; Pineda I; Rodríguez G; Fleta J; Giner A; Juste MG; Sarría A; Bueno M
Horm Metab Res; 2002 Jul; 34(7):394-9. PubMed ID: 12189588
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
